MDA Resource Center: We’re Here For You
Our trained specialists are here to provide one-on-one support for every part of your journey. Send a message below or call us at 1-833-ASK-MDA1 (1-833-275-6321). If you live outside the U.S., we may be able to connect you to muscular dystrophy groups in your area, but MDA programs are only available in the U.S.
Grant - Spring 2014 - DMD - Erica Reeves, Ph.D.

Erica Reeves, a biologist and vice president of research and operations at ReveraGen BioPharma, was awarded an MDA translational research grant totaling of $1,015,200 over one year to conduct the first human trial of VBP15, an experimental drug in development to treat Duchenne muscular dystrophy (DMD). This first trial will be in healthy volunteers. VBP15 is designed to combat inflammation and improve membrane stability in DMD-affected muscles and to provide the benefits of corticosteroid drugs like prednisone without or with reduced side effects. The grant was awarded through MDA's Venture Philanthropy (MVP) program.
Funding for this MDA translational research grant began June 2, 2014.
Grantee: DMD - Erica Reeves, Ph.D.
Grant type: Research Grant
Award total:
Institution:
Country: